Share on :

Asset Summary

Daily Performance Report for XBI ETF: Sep 18, 2024

Summary: The day started with XBI ETF opening at $100.94 and closing at $101.31. The ETF showed resilience throughout the day, with the highest price observed at $102.97 and the lowest at $100.33. The underlying asset had a trading range of $2.64 Overall, it was a positive trading day for XBI ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $0.37 or 0.37% in the closing price from the opening to the closing price over the day.

Volume Analysis: Trading volume for XBI ETF was 11,426,444 units during Sep 18, 2024, indicating active market participation and investor interest.

Opening Price: The day started at $100.94.

Highest Price: The highest price observed during the day was $102.97.

Lowest Price: The lowest price observed during the day was $100.33.

Closing Price: The day ended at $101.31.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Unleash Your XBI Trading Now

Maximize your trading efficiency with RankMyTrade Online. Our advanced trading system provides detailed insights and actionable strategies for XBI. Don’t wait—Start optimizing your trades today and see how our platform can help you achieve your trading goals!

Boost Performance Now

Frequently Asked Questions

XBI typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF.

Investors can purchase shares of XBI through a brokerage account. It is traded on major stock exchanges under the ticker symbol "XBI" and can be bought and sold like other stocks and ETFs.

Factors influencing XBI’s performance include biotech industry trends, regulatory changes, clinical trial outcomes, market sentiment, and broader economic conditions. The ETF’s performance is also affected by the performance of the underlying index.

Key performance metrics for XBI include its net asset value (NAV), expense ratio, average daily trading volume, and total return over various periods (e.g., 1-year, 5-year). NAV reflects the per-share value of the ETF, while total return measures the performance of the fund.

XBI has an expense ratio of approximately 0.35%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

Risks include high volatility and sector-specific risks associated with biotechnology companies. The biotech sector can be highly sensitive to regulatory changes, clinical trial results, and market sentiment, which can lead to significant fluctuations in XBI’s value.

Similar ETFs to XBI include: IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotech and pharmaceutical companies; LABU (Direxion Daily S&P Biotech Bull 3X Shares), a leveraged ETF seeking to provide three times the daily performance of the S&P Biotechnology Select Industry Index; and IBD (iShares U.S. Biotechnology ETF), which provides exposure to U.S. biotechnology companies, tracking the NYSE Arca Biotechnology Index.

XBI’s focus on the biotechnology sector means its performance is closely tied to developments and trends in biotech, such as drug approvals, research and development advancements, and regulatory changes. The ETF’s performance can be more volatile compared to broader indices due to the specific risks and opportunities within the biotech sector.

Yes, XBI can be held in retirement accounts such as IRAs or 401(k)s. It is important to consider how it fits within your overall investment strategy and risk tolerance given its focus on the biotech sector.

Historical performance data for XBI includes past returns, NAV, and volatility. Investors can review performance charts and reports to assess how XBI has tracked its index and how its value has changed over time.

Maximize Your XBI Trading Now

Experience the future of trading with Rankmytrade. Our advanced system delivers in-depth analysis and insights for XBI, utilizing state-of-the-art technical tools and strategies. Start optimizing your trades today and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs